At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Antitussive Effect of a Naturally Flavored, Multi-Component Syrup Containing Diphenhydramine, Compared With Dextromethorphan and Placebo
In Brief
A Phase 4 clinical trial evaluating diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo, diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan, and 4 other interventions for Cough Reflex Sensitivity. Completed, enrolled 22 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the antitussive (cough-suppressing) effects of two liquid medications: a combination of diphenhydramine and phenylephrine in a naturally cocoa flavoring, and, dextromethorphan syrup, compared with placebo.
Study Details
Timeline
Interventions
diphenhydramine 25 mg and phenylephrine 10 mg; dextromethorphan 30 mg; placebo.
diphenhydramine 25 mg and phenylephrine 10 mg; placebo; dextromethorphan 30 mg.
dextromethorphan 30 mg; diphenhydramine 25 mg and phenylephrine 10 mg; placebo
dextromethorphan 30 mg; placebo; diphenhydramine 25 mg and phenylephrine 10 mg
placebo; diphenhydramine 25 mg and phenylephrine 10 mg; dextromethorphan 30 mg
placebo; dextromethorphan 30 mg; diphenhydramine 25 mg and phenylephrine 10 mg